These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9927041)

  • 1. Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy.
    Li Y; Pong RC; Bergelson JM; Hall MC; Sagalowsky AI; Tseng CP; Wang Z; Hsieh JT
    Cancer Res; 1999 Jan; 59(2):325-30. PubMed ID: 9927041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells.
    Shirakawa T; Hamada K; Zhang Z; Okada H; Tagawa M; Kamidono S; Kawabata M; Gotoh A
    Clin Cancer Res; 2004 Jul; 10(13):4342-8. PubMed ID: 15240520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectopic expression of the coxsackievirus and adenovirus receptor increases susceptibility to adenoviral infection in the human cervical cancer cell line, SiHa.
    Kim JS; Lee SH; Cho YS; Kim YH; Lee JH
    Biochem Biophys Res Commun; 2001 Oct; 288(1):240-4. PubMed ID: 11594779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy.
    Okegawa T; Li Y; Pong RC; Bergelson JM; Zhou J; Hsieh JT
    Cancer Res; 2000 Sep; 60(18):5031-6. PubMed ID: 11016624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of increased coxsackie and adenovirus receptor gene expression and adenovirus uptake by phytoestrogen and histone deacetylase inhibitor in human bladder cancer cells and the potential clinical application.
    Pong RC; Roark R; Ou JY; Fan J; Stanfield J; Frenkel E; Sagalowsky A; Hsieh JT
    Cancer Res; 2006 Sep; 66(17):8822-8. PubMed ID: 16951199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A histone deacetylase inhibitor enhances adenoviral infection of renal cancer cells.
    Okegawa T; Sayne JR; Nutahara K; Pong RC; Saboorian H; Kabbani W; Higashihara E; Hsieh JT
    J Urol; 2007 Mar; 177(3):1148-56. PubMed ID: 17296436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells.
    Fechner H; Wang X; Wang H; Jansen A; Pauschinger M; Scherübl H; Bergelson JM; Schultheiss HP; Poller W
    Gene Ther; 2000 Nov; 7(22):1954-68. PubMed ID: 11127584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structure.
    Okegawa T; Pong RC; Li Y; Bergelson JM; Sagalowsky AI; Hsieh JT
    Cancer Res; 2001 Sep; 61(17):6592-600. PubMed ID: 11522659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus facilitated infection of human cells with ecotropic retrovirus.
    Scott-Taylor TH; Gallardo HF; Gänsbacher B; Sadelain M
    Gene Ther; 1998 May; 5(5):621-9. PubMed ID: 9797866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.
    Li D; Duan L; Freimuth P; O'Malley BW
    Clin Cancer Res; 1999 Dec; 5(12):4175-81. PubMed ID: 10632357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAR is a cell-cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone, TNFalpha, and TGFbeta.
    Brüning A; Runnebaum IB
    Gene Ther; 2003 Feb; 10(3):198-205. PubMed ID: 12571626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced transgene expression in urothelial cancer gene therapy with histone deacetylase inhibitor.
    Okegawa T; Nutahara K; Pong RC; Higashihara E; Hsieh JT
    J Urol; 2005 Aug; 174(2):747-52. PubMed ID: 16006969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of adenovirus-p16 on bladder cancer cell lines can be overcome by the addition of butyrate.
    Lee CT; Seol JY; Park KH; Yoo CG; Kim YW; Ahn C; Song YW; Han SK; Han JS; Kim S; Lee JS; Shim YS
    Clin Cancer Res; 2001 Jan; 7(1):210-4. PubMed ID: 11205911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells.
    Sachs MD; Ramamurthy M; Poel Hv; Wickham TJ; Lamfers M; Gerritsen W; Chowdhury W; Li Y; Schoenberg MP; Rodriguez R
    Cancer Gene Ther; 2004 Jul; 11(7):477-86. PubMed ID: 15118762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
    Li X; Jung C; Liu YH; Bae KH; Zhang YP; Zhang HJ; Vanderputten D; Jeng MH; Gardner TA; Kao C
    J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel adenoviral gene delivery system targeted against head and neck cancer.
    Li D; Guang W; Abuzeid WM; Roy S; Gao GP; Sauk JJ; O'Malley BW
    Laryngoscope; 2008 Apr; 118(4):650-8. PubMed ID: 18176343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of transfection rates on head and neck squamous cell cancer by a novel adenovirus: an in vivo and in vitro study.
    Lalonde ES; Beyer G; Friedlander PL; Kolls JK
    Head Neck; 2002 Dec; 24(12):1038-46. PubMed ID: 12454941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of the adenoviral sensitivity of human ovarian cancer cells by transient expression of coxsackievirus and adenovirus receptor (CAR).
    Kim JS; Lee SH; Cho YS; Choi JJ; Kim YH; Lee JH
    Gynecol Oncol; 2002 May; 85(2):260-5. PubMed ID: 11972385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro efficacy of Fas ligand gene therapy for the treatment of bladder cancer.
    Sudarshan S; Holman DH; Hyer ML; Voelkel-Johnson C; Dong JY; Norris JS
    Cancer Gene Ther; 2005 Jan; 12(1):12-8. PubMed ID: 15514684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head and neck cancer cells are efficiently infected by Ad5/35 hybrid virus.
    Suominen E; Toivonen R; Grenman R; Savontaus M
    J Gene Med; 2006 Oct; 8(10):1223-31. PubMed ID: 16941521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.